|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| HTS Technologies | ||||||||||||||||
| July 25, 2001 | ||||||||||||||||
|
The Commonwealth Institute, London 2001-11-27 HTS Technologies will be the premier high throughput screening event for chemistry and biology, providing delegates with a first-class opportunity to keep up-to-date with the latest miniaturisation, automation and screening technologies. The event will include: Sessions: - Business Strategy - Cell-based assays - Applications for screening - Lead Generation and Optimisation - Target Identification and Validation - Miniaturisation and Automation - Assay Development/ ADME Tox - Virtual Screening, Data Mining and Informatics - Technology Tutorials There will be no add on workshops or streaming at the event |
||||||||||||||||
| Organized by: | IBC Life Sciences | |||||||||||||||
| Invited Speakers: | Keynote presentations: - Prof.Graham Boulnois, Head of Lead Generation for Drug Innovation and Approval, Aventis Pharma AG, Germany - Dr Barry Ross, CEO, Affymax - Dr Peter Schultz, SCRIPS Research Institute |
|||||||||||||||
| Deadline for Abstracts: | ||||||||||||||||
| Registration: | ||||||||||||||||
| E-mail: | cust.serv@informa.com | |||||||||||||||
| Posted by: | Chris Marshall | |||||||||||||||
| Host: | dc-01.informa.com | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||